COVID-19 outcomes in patients with psoriasis and psoriatic arthritis: A prospective cohort study

JAAD Int. 2022 Sep:8:31-33. doi: 10.1016/j.jdin.2022.03.011. Epub 2022 Mar 28.

¹ Ronald O. Perelman Department of Dermatology, NYU Grossman School of Medicine, New York, New York.
² Division of Rheumatology, Department of Medicine, NYU Grossman School of Medicine, New York, New York.

No abstract available

Keywords: COVID-19; coronavirus; immune-mediated inflammatory disease; immunomodulators; psoriasis; psoriatic arthritis.